Suvretta Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-58,425
Closed -$150K 113
2024
Q2
$150K Sell
58,425
-1,541,575
-96% -$3.96M 0.01% 97
2024
Q1
$7.87M Buy
+1,600,000
New +$7.87M 0.29% 53